Pacific Biosciences of California, Inc. (PACB) Posts Q2 EPS Loss of $0.42

Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q2 EPS of ($0.42), $0.20 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $4.1 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Children's Place (PLCE) Misses Q2 EPS by 20c
• Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance